- Home
- BNTX vs CCJ Comparison
BNTX vs CCJ Comparison
Compare BNTX & CCJ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BNTX | CCJ |
|---|---|---|
| Founded | 2008 | 1987 |
| Country | Germany | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Other Metals and Minerals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.8B | 45.6B |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | BNTX | CCJ |
|---|---|---|
| Price | $94.14 | $93.61 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 6 |
| Target Price | ★ $137.40 | $114.38 |
| AVG Volume (30 Days) | 1.6M | ★ 3.6M |
| Earning Date | 11-03-2025 | 11-05-2025 |
| Dividend Yield | N/A | ★ 0.19% |
| EPS Growth | N/A | ★ 364.36 |
| EPS | N/A | ★ 0.87 |
| Revenue | ★ $3,698,814,972.00 | $2,487,042,049.00 |
| Revenue This Year | $2.03 | $10.12 |
| Revenue Next Year | N/A | $6.89 |
| P/E Ratio | ★ N/A | $105.72 |
| Revenue Growth | 3.70 | ★ 23.88 |
| 52 Week Low | $81.20 | $35.00 |
| 52 Week High | $129.27 | $110.16 |
Technical Indicators
Market Signals| Indicator | BNTX | CCJ |
|---|---|---|
| Relative Strength Index (RSI) | 42.08 | 56.25 |
| Support Level | $91.32 | $84.29 |
| Resistance Level | $93.76 | $96.57 |
| Average True Range (ATR) | 2.16 | 4.05 |
| MACD | -0.04 | 0.18 |
| Stochastic Oscillator | 34.20 | 75.41 |
Price Performance
Historical ComparisonAbout BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.
About CCJ Cameco Corporation
Cameco Corp is a provider of uranium needed to generate clean, reliable baseload electricity around the globe. one of those uranium producers. It has three reportable segments, Uranium, Fuel Services, and Westinghouse. It derives maximum revenue from the Westinghouse Segment. It has some projects namely; Millennium, Yeelirrie, Kintyre, and Exploration. The company operates in Canada, Kazakhstan, Germany, Australia, and the United States.